185 related articles for article (PubMed ID: 23802180)
21. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
22. AGR2 as a potential biomarker of human lung adenocarcinoma.
Chung K; Nishiyama N; Wanibuchi H; Yamano S; Hanada S; Wei M; Suehiro S; Kakehashi A
Osaka City Med J; 2012 Jun; 58(1):13-24. PubMed ID: 23094510
[TBL] [Abstract][Full Text] [Related]
23. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
24. Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.
Ha ES; Choi S; In KH; Lee SH; Lee EJ; Lee SY; Kim JH; Shin C; Shim JJ; Kang KH; Phark S; Sul D
Clin Biochem; 2013 Mar; 46(4-5):369-77. PubMed ID: 23200884
[TBL] [Abstract][Full Text] [Related]
25. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
[TBL] [Abstract][Full Text] [Related]
26. Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.
Uchida A; Samukawa T; Kumamoto T; Ohshige M; Hatanaka K; Nakamura Y; Mizuno K; Higashimoto I; Sato M; Inoue H
BMC Pulm Med; 2017 Dec; 17(1):195. PubMed ID: 29233112
[TBL] [Abstract][Full Text] [Related]
27. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
[TBL] [Abstract][Full Text] [Related]
28. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
[TBL] [Abstract][Full Text] [Related]
29. Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry.
Plymoth A; Yang Z; Löfdahl CG; Ekberg-Jansson A; Dahlbäck M; Fehniger TE; Marko-Varga G; Hancock WS
Clin Chem; 2006 Apr; 52(4):671-9. PubMed ID: 16497942
[TBL] [Abstract][Full Text] [Related]
30. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
31. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
32. Comparative assessment of the diagnostic value of transbronchial lung biopsy and bronchoalveolar lavage fluid cytology in lung cancer.
Binesh F; Pirdehghan A; Mirjalili MR; Samet M; Majomerd ZA; Akhavan A
Asian Pac J Cancer Prev; 2015; 16(1):201-4. PubMed ID: 25640352
[TBL] [Abstract][Full Text] [Related]
33. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.
Ahrendt SA; Chow JT; Xu LH; Yang SC; Eisenberger CF; Esteller M; Herman JG; Wu L; Decker PA; Jen J; Sidransky D
J Natl Cancer Inst; 1999 Feb; 91(4):332-9. PubMed ID: 10050866
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.
Ajona D; Razquin C; Pastor MD; Pajares MJ; Garcia J; Cardenal F; Fleischhacker M; Lozano MD; Zulueta JJ; Schmidt B; Nadal E; Paz-Ares L; Montuenga LM; Pio R
PLoS One; 2015; 10(3):e0119878. PubMed ID: 25799154
[TBL] [Abstract][Full Text] [Related]
35. Role of bronchoalveolar lavage in diagnosing pulmonary infections and malignancies: Experience from a tertiary care center.
Zaidi A; Kaur H; Gupta P; Gupta N; Srinivasan R; Dey P; Rohilla M; Rajwanshi A; Bal A; Agarwal R
Diagn Cytopathol; 2020 Dec; 48(12):1290-1299. PubMed ID: 32770787
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of tissue polypeptide antigen (TPA) in the two bronchoalveolar lavage fractions of lung cancer patients.
Prados C; Alvarez-Sala R; Gómez de Terrero J; Callol L; García Río F; Gómez Carrera L; Gomez de Terreros Caro J; Alvarez-Sala JL; Espinós D; Villamor J
Jpn J Clin Oncol; 2000 May; 30(5):215-20. PubMed ID: 10857498
[TBL] [Abstract][Full Text] [Related]
37. Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases.
Cruz MJ; Curull V; Pijuan L; Álvarez-Simón D; Sánchez-Font A; de Gracia J; Culebras M; Ferrer J
Arch Bronconeumol; 2017 Jun; 53(6):318-323. PubMed ID: 27914752
[TBL] [Abstract][Full Text] [Related]
38. CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers.
Charalabopoulos K; Karakosta A; Bablekos G; Golias C; Charalabopoulos A; Tsanou E; Peschos D; Zoganas L; Batistatou A
Med Oncol; 2007; 24(2):219-25. PubMed ID: 17848747
[TBL] [Abstract][Full Text] [Related]
39. Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer.
Calogero AE; Polosa R; Neville E; D'Agata R
J Endocrinol Invest; 1995 May; 18(5):354-8. PubMed ID: 7594223
[TBL] [Abstract][Full Text] [Related]
40. Glycoproteomic Alterations in Drug-Resistant Nonsmall Cell Lung Cancer Cells Revealed by Lectin Magnetic Nanoprobe-Based Mass Spectrometry.
Waniwan JT; Chen YJ; Capangpangan R; Weng SH; Chen YJ
J Proteome Res; 2018 Nov; 17(11):3761-3773. PubMed ID: 30261726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
